Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Gynecologic Oncology
|
April 28, 2015
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays
Shreya Raghavan, Maria R Ward, Katelyn R Rowley, et al.
Plos One
|
May 11, 2019
Integrated cancer tissue engineering models for precision medicine
Michael E Bregenzer, Eric N Horst, Pooja Mehta, et al.
Acta Biomaterialia
|
May 3, 2021
Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model
Eric N Horst, Michael E Bregenzer, Pooja Mehta, et al.
Journal of Visualized Experiments : Jove
|
July 23, 2019
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Michael E Bregenzer, Ciara Davis, Eric N Horst, et al.
Frontiers in Bioengineering and Biotechnology
|
April 11, 2022
A Bioreactor for 3D <i>In Vitro</i> Modeling of the Mechanical Stimulation of Osteocytes
Koh Meng Aw Yong, Eric Horst, Dylan Neale, et al.
Current Topics in Medicinal Chemistry
|
March 31, 2011
Artificial hematopoietic stem cell niche: bioscaffolds to microfluidics to mathematical simulations
Maruti Didwania, Anjani Didwania, Geeta Mehta, et al.
Acta Biomaterialia
|
February 8, 2026
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer cells, carcinoma associated fibroblasts, and macrophages
Kathleen M Burkhard, Ayush Semwal, Benjamin K Johnson, et al.
Research Square
|
June 30, 2025
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer (HGSC) cells, carcinoma associated fibroblasts, and macrophages
Kathleen M Burkhard, Ayush Semwal, Benjamin K Johnson, et al.
Cancers
|
April 3, 2021
The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma
Mikhail S Chesnokov, Imran Khan, Yeonjung Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2017
Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
Shreya Raghavan, Pooja Mehta, Maria R Ward, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Gynecologic Oncology
|
April 28, 2015
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays
Shreya Raghavan, Maria R Ward, Katelyn R Rowley, et al.
Plos One
|
May 11, 2019
Integrated cancer tissue engineering models for precision medicine
Michael E Bregenzer, Eric N Horst, Pooja Mehta, et al.
Acta Biomaterialia
|
May 3, 2021
Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model
Eric N Horst, Michael E Bregenzer, Pooja Mehta, et al.
Journal of Visualized Experiments : Jove
|
July 23, 2019
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Michael E Bregenzer, Ciara Davis, Eric N Horst, et al.
Frontiers in Bioengineering and Biotechnology
|
April 11, 2022
A Bioreactor for 3D <i>In Vitro</i> Modeling of the Mechanical Stimulation of Osteocytes
Koh Meng Aw Yong, Eric Horst, Dylan Neale, et al.
Current Topics in Medicinal Chemistry
|
March 31, 2011
Artificial hematopoietic stem cell niche: bioscaffolds to microfluidics to mathematical simulations
Maruti Didwania, Anjani Didwania, Geeta Mehta, et al.
Acta Biomaterialia
|
February 8, 2026
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer cells, carcinoma associated fibroblasts, and macrophages
Kathleen M Burkhard, Ayush Semwal, Benjamin K Johnson, et al.
Research Square
|
June 30, 2025
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer (HGSC) cells, carcinoma associated fibroblasts, and macrophages
Kathleen M Burkhard, Ayush Semwal, Benjamin K Johnson, et al.
Cancers
|
April 3, 2021
The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma
Mikhail S Chesnokov, Imran Khan, Yeonjung Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2017
Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
Shreya Raghavan, Pooja Mehta, Maria R Ward, et al.
Page
of 7